The Atellica® COVID-19 Severity Algorithm* is an EUO AI-based tool to help identify SARS-CoV-2 patients at risk of progressing to severe outcomes. By combining age and lab results for D-dimer, Lactate dehydrogenase (LDH), Lymphocyte %, Eosinophil %, Creatinine, C-reactive protein (CRP), Ferritin, PT-INR and Cardiac Troponin-I, the algorithm generates a COVID-19 clinical severity score and likelihood of progression to:
- Ventilator use,
- End-stage organ damage, and
- 30-day in-hospital mortality
The EUO algorithm is currently being evaluated by laboratories around the world. A potential future interface with Atellica® Data Manager is planned to further expand the middleware’s clinical decision support capabilities.**
*The product is intended for educational use only (EUO). It is not for clinical or patient care, diagnosis, treatment, or to cure or prevent any disease.
**Under development and not available for sale. Future availability cannot be guaranteed